AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 162 min read$SNPS

Ghazi Sassine sold $6.7M of SNPS

Ghazi Sassine (PRESIDENT AND CEO) sold 14,603 shares of SYNOPSYS INC (SNPS) at $458.96 ($6.70M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ghazi Sassine
Published Jun 16, 2026, 8:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$SNPS
Neutral
high confidence
Mentioned
$SNPS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSNeutralLow
01

Why it matters

The disclosure can slightly influence sentiment, but it does not introduce new fundamentals; the pre-arranged nature lowers interpretability as a near-term negative catalyst.

02

Market read

A single-day CEO sale (~$6.7M) is disclosed; likely modest sentiment impact only.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or regulatory/product news, the signal is typically weak.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-16 for a sale executed 2026-06-15

Background

The article is an SEC Form 4 insider transaction: CEO Ghazi Sassine sold shares of Synopsys on 10b5-1.

Company-level read

Ticker impact

$SNPSNeutralHigh confidence
Context

Synopsys CEO Ghazi Sassine sold 14,603 shares for about $6.7M under a pre-arranged 10b5-1 plan disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect should be modest and sentiment-driven rather than catalyst-driven.

Evidence & confidence

The filing is a routine Form 4 open-market sale with an explicitly pre-arranged 10b5-1 plan, providing no new operating or financial information.

Market effects

Sector

No direct sector read-through; this is company-specific insider transaction disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • issuer
    Synopsys

    Company whose CEO insider sale is disclosed via SEC Form 4.

  • insider
    Ghazi Sassine

    President and CEO who sold 14,603 shares.

  • trading mechanism
    10b5-1 plan

    Pre-arranged plan that reduces the inference of new private information.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

SNPS insider trading history →

Related articles

SEP 8
$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

gurufocus.com2 min
SEP 8
$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.

yahoo.com2 min
SEP 4
$SNPSMedAI 8/10

Synopsys Falls as Strong Results Fail to Clear a High Bar

Synopsys (SNPS) shares fell 5.9% after reporting Q3 revenue of $2.48B and EPS of $3.91, both above guidance. The company raised full-year targets to $9.715B revenue and $15.07 EPS, but investors reacted negatively due to modest outlook increases, restructuring costs, and acquisition-related expenses. Insider sales and mixed hedge fund activity were also noted.

quiverquant.com2 min